×

Money & Markets

Stocks lose more ground on fears a recession may be looming

NEW YORK — Good news on the economy remains bad news for Wall Street, as stocks fell sharply Friday on worries a still-strong U.S jobs market may actually make a recession more likely. The S&P 500 ended 2.8 percent lower after briefly dropping 3.3 percent as traders weighed a government ...

Hospital chain attack part of ongoing cybersecurity concerns

CHICAGO — Diverted ambulances. Cancer treatment delayed. Electronic health records offline. These are just some of ripple effects of an apparent cyberattack on a major nonprofit health system that disrupted operations throughout the U.S. While CommonSpirit Health confirmed it experienced an ...

Big Brazilian gold refiner delisted amid Amazon mining probe

MIAMI — One of Brazil’s biggest gold refiners, which processes gold suspected of being mined illegally in the Amazon rainforest, has been stripped of an important industry seal of approval that global manufacturers from Apple to Tesla rely on to root out abuses in their supply chains. An ...

Deal back on? Elon Musk gets closer to buying Twitter

The tumultuous saga of Elon Musk’s on-again off-again purchase of Twitter took a turn toward a conclusion Tuesday after the mercurial Tesla CEO proposed to buy the company at the originally agreed-on price of $44 billion. Musk made the surprising turnaround not on Twitter, as has been his ...

Senate passes stopgap bill to avert shutdown, aid Ukraine

WASHINGTON — The Senate passed a short-term spending bill on Thursday that would avert a partial government shutdown when the current fiscal year ends at midnight Friday and provide another infusion of military and economic aid to Ukraine as it seeks to repel Russia’s brutal invasion. The ...

Alzheimer’s drug shows promise in early results of study

Shares of Biogen and other drugmakers researching Alzheimer’s disease soared Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-stage study. The drugmaker said early results showed that its treatment, lecanemab, reduced patient ...